Senseonics Holdings, Inc. Common Stock (SENS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $579.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
Senseonics Holdings, Inc. Common Stock (SENS) Earnings: Report Dates and Results
Senseonics Holdings, Inc. Common Stock (SENS) is confirmed to report earnings on Mar 1, 2027, after the close. In the quarter ended Sep 30, 2026, Senseonics Holdings, Inc. Common Stock reported EPS of -$0.50, below the -$0.49 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SENS has a confirmed report date of Mar 1, 2027, after the close.
SENS Earnings Call
The latest SENS earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 39 quarters below that had an estimate, SENS beat 12, missed 24 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $19.56M, up 141.5% from $8.10M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.50 | -$0.49 | -$0.64 - -$0.41 | -2.04% | Miss | N/A | 7 | 2 up, 0 down | Nov 9, 2026 | $19.56M |
| Jun 30, 2026 | -$0.63 | -$0.55 | -$0.73 - -$0.50 | -14.55% | Miss | N/A | 6 | 5 up, 1 down | Aug 6, 2026 | $14.48M |
| Mar 31, 2026 | -$0.71 | -$0.70 | -$0.74 - -$0.62 | -1.43% | Miss | N/A | 7 | 1 up, 6 down | May 7, 2026 | $11.71M |
| Dec 31, 2025 | -$0.46 | -$0.02 | N/A | N/A | N/A | N/A | 7 | 1 up, 0 down | Mar 2, 2026 | $14.26M |
| Sep 30, 2025 | -$0.43 | -$0.33 | N/A | -30.30% | Miss | N/A | 5 | 2 up, 0 down | Nov 5, 2025 | $8.10M |
| Jun 30, 2025 | -$0.40 | -$0.40 | -$0.40 - -$0.40 | 0.00% | In line | N/A | 6 | 2 up, 0 down | Aug 6, 2025 | $6.65M |
| Mar 31, 2025 | -$0.40 | -$0.47 | -$0.60 - -$0.40 | +14.89% | Beat | N/A | 3 | 2 up, 0 down | May 8, 2025 | $6.26M |
| Dec 31, 2024 | -$0.02 | -$0.03 | -$0.03 - -$0.03 | +33.33% | Beat | N/A | 2 | 0 up, 1 down | Mar 3, 2025 | $8.30M |
| Sep 30, 2024 | -$0.80 | -$0.70 | -$0.80 - -$0.60 | -14.29% | Miss | N/A | 5 | 0 up, 0 down | Nov 7, 2024 | $4.26M |
| Jun 30, 2024 | -$0.66 | -$0.60 | -$0.60 - -$0.60 | -10.00% | Miss | N/A | 4 | 0 up, 0 down | Aug 8, 2024 | $4.87M |
| Mar 31, 2024 | -$0.60 | -$0.60 | -$0.60 - -$0.60 | 0.00% | In line | N/A | 3 | 0 up, 0 down | May 13, 2024 | $5.05M |
| Dec 31, 2023 | -$0.03 | -$0.04 | -$0.05 - -$0.04 | +25.00% | Beat | -250.0% | 3 | 0 up, 0 down | Feb 29, 2024 | $8.03M |
| Sep 30, 2023 | -$0.95 | -$0.70 | -$0.80 - -$0.60 | -35.71% | Miss | N/A | 4 | 0 up, 0 down | Nov 9, 2023 | $6.10M |
| Jun 30, 2023 | -$0.71 | -$0.60 | -$1.00 - -$0.60 | -18.33% | Miss | N/A | 4 | 0 up, 0 down | Aug 10, 2023 | $4.13M |
| Mar 31, 2023 | -$0.93 | -$0.73 | -$0.80 - -$0.60 | -27.40% | Miss | N/A | 3 | 0 up, 0 down | May 9, 2023 | $4.14M |
| Dec 31, 2022 | $0.02 | -$0.04 | N/A | +150.00% | Beat | -90.5% | N/A | 0 up, 0 down | Mar 15, 2023 | $5.57M |
| Sep 30, 2022 | -$2.60 | -$0.85 | N/A | -205.88% | Miss | N/A | N/A | 0 up, 0 down | Nov 8, 2022 | $4.62M |
| Jun 30, 2022 | -$0.92 | -$0.73 | N/A | -26.03% | Miss | N/A | N/A | 0 up, 0 down | Aug 9, 2022 | $3.71M |
| Mar 31, 2022 | -$0.65 | -$0.73 | -$0.80 - -$0.40 | +10.96% | Beat | N/A | 4 | 0 up, 0 down | May 10, 2022 | $2.48M |
| Dec 31, 2021 | $0.21 | -$0.03 | -$0.04 - -$0.01 | +800.00% | Beat | N/A | 6 | 0 up, 0 down | Mar 1, 2022 | $4.01M |
| Sep 30, 2021 | -$0.68 | -$1.28 | -$2.60 - -$0.60 | +46.88% | Beat | N/A | 7 | N/A | Nov 9, 2021 | $3.53M |
| Jun 30, 2021 | -$0.91 | -$0.48 | -$1.00 - $1.00 | -89.58% | Miss | N/A | 6 | N/A | Aug 9, 2021 | $3.29M |
| Mar 31, 2021 | -$0.84 | -$0.84 | -$1.60 - -$0.80 | 0.00% | In line | N/A | 6 | N/A | May 13, 2021 | $2.85M |
| Dec 31, 2020 | -$0.44 | -$0.09 | -$0.23 - -$0.05 | -388.89% | Miss | N/A | 6 | N/A | Mar 4, 2021 | $3.88M |
| Sep 30, 2020 | -$1.47 | -$1.33 | -$1.60 - -$0.80 | -10.53% | Miss | N/A | 6 | N/A | Nov 9, 2020 | $767000 |
| Jun 30, 2020 | -$1.49 | -$1.96 | -$2.40 - -$1.00 | +23.98% | Beat | N/A | 6 | N/A | Aug 10, 2020 | $261000 |
| Mar 31, 2020 | -$0.19 | -$0.13 | -$0.18 - -$0.04 | -46.15% | Miss | N/A | 8 | N/A | Jun 9, 2020 | $36000 |
| Dec 31, 2019 | -$3.85 | -$3.23 | -$4.20 - -$2.40 | -19.20% | Miss | N/A | 9 | N/A | Mar 12, 2020 | $8.95M |
| Sep 30, 2019 | -$3.54 | -$3.20 | -$4.00 - -$2.60 | -10.63% | Miss | N/A | 10 | N/A | Nov 12, 2019 | $4.32M |
| Jun 30, 2019 | -$3.40 | -$3.28 | -$3.40 - -$2.80 | -3.66% | Miss | N/A | 9 | N/A | Aug 7, 2019 | $4.61M |
| Mar 31, 2019 | -$3.40 | -$2.73 | -$3.40 - -$1.20 | -24.54% | Miss | N/A | 9 | N/A | May 9, 2019 | $3.42M |
| Dec 31, 2018 | -$0.03 | -$0.14 | -$0.20 - -$0.12 | +78.57% | Beat | N/A | 9 | N/A | Mar 12, 2019 | $7.19M |
| Sep 30, 2018 | -$2.80 | -$2.66 | -$3.40 - -$2.40 | -5.26% | Miss | N/A | 6 | N/A | Nov 8, 2018 | $5.16M |
| Jun 30, 2018 | -$4.60 | -$2.72 | -$3.00 - -$2.40 | -69.12% | Miss | N/A | 6 | N/A | Aug 8, 2018 | $3.62M |
| Mar 31, 2018 | -$3.20 | -$2.40 | -$2.80 - -$2.00 | -33.33% | Miss | N/A | 5 | N/A | May 10, 2018 | $2.95M |
| Dec 31, 2017 | -$0.12 | -$0.13 | -$0.15 - -$0.11 | +7.69% | Beat | N/A | 4 | N/A | Mar 13, 2018 | $2.91M |
| Sep 30, 2017 | -$2.60 | -$2.55 | -$3.20 - -$2.20 | -1.96% | Miss | N/A | 4 | N/A | Oct 31, 2017 | $2.10M |
| Jun 30, 2017 | -$2.40 | -$2.65 | -$3.00 - -$2.00 | +9.43% | Beat | N/A | 4 | N/A | Aug 9, 2017 | $814000 |
| Mar 31, 2017 | -$2.80 | -$2.45 | N/A | -14.29% | Miss | N/A | N/A | N/A | May 4, 2017 | $553000 |
| Dec 31, 2016 | -$0.10 | -$0.12 | N/A | +16.67% | Beat | N/A | N/A | N/A | Feb 23, 2017 | $276000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.69, after -$2.08 the year before. It was -$8.10 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.69 | N/A |
| Dec 31, 2024 | -$2.08 | N/A |
| Dec 31, 2023 | -$2.62 | N/A |
| Dec 31, 2022 | -$4.15 | N/A |
| Dec 31, 2021 | -$2.22 | N/A |
| Dec 31, 2020 | -$3.59 | N/A |
| Dec 31, 2019 | -$14.19 | N/A |
| Dec 31, 2018 | -$10.63 | N/A |
| Dec 31, 2017 | -$7.92 | N/A |
| Dec 31, 2016 | -$8.10 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,100 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,126 | 11 | |
| 2026Q1 | Mar 31, 2026 | 5,571 | 11 | |
| 2025Q4 | Dec 31, 2025 | 7,198 | 12 | |
| 2025Q3 | Sep 30, 2025 | 6,346 | 12 | |
| 2025Q2 | Jun 30, 2025 | 5,197 | 9 | |
| 2025Q1 | Mar 31, 2025 | 4,024 | 6 | |
| 2024Q3 | Sep 30, 2024 | 2,854 | 6 | |
| 2024Q2 | Jun 30, 2024 | 3,504 | 6 |
2026Q3 Earnings Call
Opening remarks
Jeremy Feffer Investor Relations Representative Thank you. This is Jeremy Feffer from LifeSci Advisors. Before we begin today, let me remind you that the company's remarks include forward-looking statements. These statements reflect management's expectations about future events, operating plans, regulatory matters, product enhancements, company performance, and other matters, and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. A list of the factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is detailed under Risk Factors and elsewhere in our annual report on Form 10-K for the year ended December 31, 2025, our 10-Q for the period ended September 30, 2026, and our other reports filed with the SEC. These documents are available on the Investor Relations section of our website at www.senseonics.com. We undertake no obligation to update publicly or revise these forward-looking statements for any reason, except as required by law. Joining me today from Senseonics are Tim Goodnow, President and Chief Executive Officer; Brian Hansen, Chief Commercial Officer; and Rick Sullivan, Chief Financial Officer. Mukul Jain, Chief Operating Officer, will also be available during the Q&A. And now I'd like to turn the call over to Tim.
Tim Goodnow President and Chief Executive Officer Thanks, Jeremy, and good afternoon, everyone. Q3 was a breakout quarter for Senseonics. Revenue reached $19.6 million, up about 140%, well more than double the prior year. It's the highest in our history and the second quarter in a row in which we have set a new mark. This is driven by a record number of new patient starts. In the U.S., revenue grew about 160% to $16.8 million. And outside the U.S., it rose about 65% to $2.8 million. Our sales are running ahead of our earlier expectations, and we are now raising full-year revenue guidance for the third time this year. We are now projecting $68 million to $70 million of full-year revenue, from our prior range of $62 million to $66 million. What's driving this? First and foremost, the product. Eversense 365 is the only CGM that delivers a full year on a single sensor with exceptional accuracy throughout and a removable transmitter that is easy on the skin. Patients feel the difference, and retention is exceeding our plan. Our execution is amplifying these advantages, and our commercial team is performing superbly. Together, we're making Eversense easier to get. Our insertion network keeps widening, reimbursement is improving, and our integration partnerships are growing. Those are the priorities we set at the start of the year, and each one is delivering. Just as telling is where our new patients are coming from: the overwhelming majority are switching from other CGMs.
Frequently Asked Questions About SENS
When is Senseonics Holdings, Inc. Common Stock's next earnings date?
Senseonics Holdings, Inc. Common Stock's next earnings report is confirmed for Mar 1, 2027, after the close.
Did SENS beat earnings estimates last quarter?
No. Senseonics Holdings, Inc. Common Stock reported EPS of -$0.50 for the quarter ended Sep 30, 2026, below the -$0.49 estimate by 2.04%.
What EPS do analysts expect from SENS next quarter?
The consensus EPS estimate for Senseonics Holdings, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.42 from 10 analysts, with estimates from -$0.53 to -$0.38.
How often does SENS beat earnings estimates?
Senseonics Holdings, Inc. Common Stock beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -1.80%.
Does SENS report before or after the market opens?
Senseonics Holdings, Inc. Common Stock is confirmed to report on Mar 1, 2027, after the market closes.
SENS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors